X0508 4 2023-09-12 false 0001412408 Phreesia, Inc. PHR 0001776729 Linetsky David C/O PHREESIA, INC. 1521 CONCORD PIKE, SUITE 301 PMB 221 WILMINGTON DE 19803 false true false false SVP, Life Sciences false Common Stock 2023-09-12 4 A false 3279.00 A 207320.00 D Common Stock 2023-09-12 4 M false 475.00 4.71 A 207795.00 D Common Stock 2023-09-12 4 M false 5689.00 8.03 A 213484.00 D Common Stock 2023-09-12 4 M false 5689.00 4.71 A 219173.00 D Common Stock 2023-09-12 4 A false 273.00 A 8081.00 I By spouse Common Stock 2023-09-13 4 S false 1977.00 20.3031 D 217196.00 D Common Stock 2023-09-13 4 S false 82.00 21.2047 D 217114.00 D Common Stock 2023-09-13 4 S false 114.00 20.3031 D 7967.00 I By spouse Common Stock 2023-09-13 4 S false 5.00 21.2047 D 7962.00 I By spouse Stock Option 8.03 2023-09-12 4 M false 5689.00 0.00 D 2029-01-16 Common Stock 5689.00 0.00 D Stock Option 4.71 2023-09-12 4 M false 475.00 0.00 D 2028-01-30 Common Stock 475.00 0.00 D Stock Option 4.71 2023-09-12 4 M false 5689.00 0.00 D 2028-08-06 Common Stock 5689.00 0.00 D Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2024 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $21.27, the closing price of the Issuer's common stock on September 12, 2023. Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's spouse's cash bonus earned for the fiscal first half of the year ending January 31, 2024 under the Issuer's Variable Compensation Plan. The Reporting Person's spouse elected to convert such portion of her earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted is based on a per share value of $21.27, the closing price of the Issuer's common stock on September 12, 2023. These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of RSUs. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.11 to $21.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.17 to $21.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option is fully vested and exercisable as of the date hereof. Alexis Lyons, as Attorney-in-Fact for David Linetsky 2023-09-14